Aralez sues Teva over Yosprala aspirin patents

25-01-2017

US-based drugs company Aralez Pharmaceuticals has filed a patent infringement complaint against Teva centring on the drug Yosprala (aspirin and omeprazole), a delayed-release aspirin.


Aralez, Teva, ANDA, FDA, Yosprala, aspirin, patent, patent infringement, generics

LSIPR